Product NDC: | 11527-162 |
Proprietary Name: | Sheffield Triple Antibiotic |
Non Proprietary Name: | Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate |
Active Ingredient(s): | 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g & nbsp; Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 11527-162 |
Labeler Name: | Faria LLC dba Sheffield Pharmaceuticals |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part333B |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20110123 |
Package NDC: | 11527-162-51 |
Package Description: | 1 TUBE in 1 CARTON (11527-162-51) > 14 g in 1 TUBE |
NDC Code | 11527-162-51 |
Proprietary Name | Sheffield Triple Antibiotic |
Package Description | 1 TUBE in 1 CARTON (11527-162-51) > 14 g in 1 TUBE |
Product NDC | 11527-162 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 20110123 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Faria LLC dba Sheffield Pharmaceuticals |
Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
Strength Number | 400; 3.5; 5000 |
Strength Unit | [USP'U]/g; mg/g; [USP'U]/g |
Pharmaceutical Classes |